Literature DB >> 19287316

Increased reelin promoter methylation is associated with granule cell dispersion in human temporal lobe epilepsy.

Katja Kobow1, Ina Jeske, Michelle Hildebrandt, Jan Hauke, Eric Hahnen, Rolf Buslei, Michael Buchfelder, Daniel Weigel, Hermann Stefan, Burkhard Kasper, Elisabeth Pauli, Ingmar Blümcke.   

Abstract

Mesial temporal sclerosis (MTS) is the most common lesion in chronic, intractable temporal lobe epilepsies (TLE) and characterized by segmental neuronal cell loss in major hippocampal segments. Another histopathological hallmark includes granule cell dispersion (GCD), an architectural disturbance of the dentate gyrus encountered in approximately 50% of patients with mesial temporal sclerosis. Reelin, which plays a key role during hippocampal development and maintenance of laminar organization, is synthesized and released by Cajal-Retzius cells of the dentate molecular layer, and previous studies have shown that Reelin transcript levels are downregulated in human temporal lobe epilepsies specimens. To investigate whether epigenetic silencing by Reelin promoter methylation may be an underlying pathogenetic mechanism of GCD, DNA was harvested from 3 microdissected hippocampal subregions (i.e. molecular and granule cell layers of the dentate gyrus and presubiculum) from 8 MTS specimens with GCD, 5 TLE samples without GCD, and 3 autopsy controls. Promoter methylation was analyzed after bisulfite treatment, cloning, and direct sequencing; immunohistochemistry was performed to identify Cajal-Retzius cells. Reelin promoter methylation was found to be greater in TLE specimens than in controls; promoter methylation correlated with GCD among TLE specimens (p < 0.0002). No other clinical or histopathological parameter (i.e. sex, age, seizure duration, medication or extent, of MTS) correlated with promoter methylation. These data support a compromised Reelin-signaling pathway and identify promoter methylation as an epigenetic mechanism in the pathogenesis of TLE.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19287316     DOI: 10.1097/NEN.0b013e31819ba737

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  68 in total

Review 1.  DNA modifications and neurological disorders.

Authors:  Yi-Lan Weng; Ran An; Jaehoon Shin; Hongjun Song; Guo-li Ming
Journal:  Neurotherapeutics       Date:  2013-10       Impact factor: 7.620

Review 2.  Epigenetic mechanisms in stroke and epilepsy.

Authors:  Jee-Yeon Hwang; Kelly A Aromolaran; R Suzanne Zukin
Journal:  Neuropsychopharmacology       Date:  2012-08-15       Impact factor: 7.853

3.  Temporal lobe epilepsy: a unique window into living human brain epigenetic gene regulation.

Authors:  Alexander Grote; Susanne Schoch; Albert J Becker
Journal:  Brain       Date:  2015-03       Impact factor: 13.501

Review 4.  The role of adenosine in epilepsy.

Authors:  Landen Weltha; Jesica Reemmer; Detlev Boison
Journal:  Brain Res Bull       Date:  2018-11-20       Impact factor: 4.077

5.  Thinking Above the Genome: Epigenetic Manipulation as a Disease-Modifying Strategy in Epilepsy.

Authors:  Nigel C Jones
Journal:  Epilepsy Curr       Date:  2018 Jul-Aug       Impact factor: 7.500

Review 6.  Comorbidities in Neurology: Is adenosine the common link?

Authors:  Detlev Boison; Eleonora Aronica
Journal:  Neuropharmacology       Date:  2015-05-13       Impact factor: 5.250

Review 7.  Epigenetics and Epilepsy.

Authors:  David C Henshall; Katja Kobow
Journal:  Cold Spring Harb Perspect Med       Date:  2015-10-05       Impact factor: 6.915

8.  Decreased astroglial monocarboxylate transporter 4 expression in temporal lobe epilepsy.

Authors:  Bei Liu; Le Niu; Ming-Zhi Shen; Lei Gao; Chao Wang; Jie Li; Li-Jia Song; Ye Tao; Qiang Meng; Qian-Li Yang; Guo-Dong Gao; Hua Zhang
Journal:  Mol Neurobiol       Date:  2014-01-25       Impact factor: 5.590

Review 9.  Finding a better drug for epilepsy: antiepileptogenesis targets.

Authors:  Katja Kobow; Stéphane Auvin; Frances Jensen; Wolfgang Löscher; Istvan Mody; Heidrun Potschka; David Prince; Alejandra Sierra; Michele Simonato; Asla Pitkänen; Astrid Nehlig; Jong M Rho
Journal:  Epilepsia       Date:  2012-10-12       Impact factor: 5.864

Review 10.  Sex, epilepsy, and epigenetics.

Authors:  Irfan A Qureshi; Mark F Mehler
Journal:  Neurobiol Dis       Date:  2014-07-04       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.